Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823652 · ClinicalTrials.gov registry record · NA
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
A NA study, sponsored by ECOG-ACRIN Cancer Research Group.
- Completed
- Registry status
- NA
- Development phase
- 601
- Enrollment target
NCT02823652: Completed NA study, sponsored by ECOG-ACRIN Cancer Research Group.
NCT02823652 is a NA study that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 601 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823652, a NA study, has completed, sponsored by ECOG-ACRIN Cancer Research Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 601 participants
- Enrollment target
Study Summary
This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potential germline mutations may increase genetic knowledge and reduce distress for patients with advanced cancer.
Primary Outcome
There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Interventions
- OTHER Survey Administration
- OTHER Genetic Testing
- OTHER Internet-Based Intervention
- OTHER Genetic Counseling
- OTHER standard genetic education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2019-12-26 |
| Phase | NA |
What the finished NCT02823652 record still lists
NCT02823652 is an interventional study that assigns participants to a tested intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.
NCT02823652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823652 about?
NCT02823652 is a clinical study titled "Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer". This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potentia...
What is the current status of trial NCT02823652?
This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2016-10-25. Estimated completion is 2019-12-26.
What interventions are being tested in trial NCT02823652?
The interventions under investigation include: Survey Administration (OTHER), Genetic Testing (OTHER), Internet-Based Intervention (OTHER), Genetic Counseling (OTHER), standard genetic education (OTHER).
Who is sponsoring clinical trial NCT02823652?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02823652's enrollment target sits among peer trials
601 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI